Seeing Is Believing
Currently out of the existing stock ratings of David Turkaly, 115 are a BUY (97.46%), 1 are a SELL (0.85%), 2 are a HOLD (1.69%).
Analyst David Turkaly works at JMP with a stock forecast success ratio of 32.61% fulfilled within 193.78 days on average.
David Turkaly’s has documented 239 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on KIDS, Orthopediatrics Corp at 07-Mar-2024.
Analyst best performing recommendations are on STIM (NEURONETICS).
The best stock recommendation documented was for STIM (NEURONETICS) at 1/8/2021. The price target of $15 was fulfilled within 11 days with a profit of $2.11 (16.37%) receiving and performance score of 14.88.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
4.5
$3 (200.00%)
3
8 months 15 days ago
14/16 (87.5%)
$-0.55 (-10.89%)
297
Buy
9
$7.5 (500.00%)
6
10 months 11 days ago
2/3 (66.67%)
$2.05 (29.50%)
81
Hold
10
11 months 2 days ago
3/3 (100%)
$1.8 (21.95%)
243
Buy
17
$15.5 (1033.33%)
12
1 years 9 months 7 days ago
0/2 (0%)
$8.43 (98.37%)
Which stock is David Turkaly is most bullish on?
Which stock is David Turkaly is most reserved on?
What Year was the first public recommendation made by David Turkaly?